Genky DrugStores Co., Ltd.
9267.T · JPX
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Revenue | ¥200,786 | ¥184,860 | ¥169,059 | ¥154,640 |
| % Growth | 8.6% | 9.3% | 9.3% | – |
| Cost of Goods Sold | ¥159,896 | ¥147,239 | ¥134,505 | ¥123,685 |
| Gross Profit | ¥40,890 | ¥37,621 | ¥34,554 | ¥30,954 |
| % Margin | 20.4% | 20.4% | 20.4% | 20% |
| R&D Expenses | ¥0 | ¥0 | ¥0 | ¥0 |
| G&A Expenses | ¥0 | ¥0 | ¥0 | ¥0 |
| SG&A Expenses | ¥31,231 | ¥23,518 | ¥23,194 | ¥21,000 |
| Sales & Mktg Exp. | ¥0 | ¥0 | ¥0 | ¥0 |
| Other Operating Expenses | ¥0 | ¥5,088 | ¥4,650 | ¥4,279 |
| Operating Expenses | ¥31,231 | ¥28,606 | ¥27,844 | ¥25,279 |
| Operating Income | ¥9,659 | ¥9,016 | ¥6,709 | ¥5,675 |
| % Margin | 4.8% | 4.9% | 4% | 3.7% |
| Other Income/Exp. Net | ¥243 | -¥213 | -¥6 | ¥409 |
| Pre-Tax Income | ¥9,902 | ¥8,803 | ¥6,704 | ¥6,084 |
| Tax Expense | ¥2,836 | ¥2,478 | ¥1,939 | ¥1,663 |
| Net Income | ¥7,066 | ¥6,324 | ¥4,764 | ¥4,420 |
| % Margin | 3.5% | 3.4% | 2.8% | 2.9% |
| EPS | 232.49 | 207.94 | 156.89 | 145.59 |
| % Growth | 11.8% | 32.5% | 7.8% | – |
| EPS Diluted | 232.02 | 207.91 | 156.79 | 145.44 |
| Weighted Avg Shares Out | 30 | 30 | 30 | 30 |
| Weighted Avg Shares Out Dil | 30 | 30 | 30 | 30 |
| Supplemental Information | – | – | – | – |
| Interest Income | ¥10 | ¥7 | ¥8 | ¥9 |
| Interest Expense | ¥216 | ¥103 | ¥70 | ¥59 |
| Depreciation & Amortization | ¥6,292 | ¥5,566 | ¥4,955 | ¥4,592 |
| EBITDA | ¥16,410 | ¥14,474 | ¥11,729 | ¥10,735 |
| % Margin | 8.2% | 7.8% | 6.9% | 6.9% |